Request for Covid-19 Impact Assessment of this Report
The global otorhinolaryngologydevices market is anticipated to experience significant growth during the forecast period due to technological advancements and rise in prevalence rate of diseases that require otorhinolaryngology devices. In addition, favorable FDA approvals & reimbursement policies in developed economies, surge in patient preference for minimally invasive surgeries, and shorter recovery time & minimal postoperative complications further drive the growth of the global otorhinolaryngology devices market. However, high cost of otorhinolaryngology instruments and procedure and stringent government regulations hinder the growth of the market globally. On the contrary, various growth opportunities from emerging economies are anticipated to provide lucrative opportunities for the otorhinolaryngology devices market growth.
The global otorhinolaryngology devices market is segmented on the basis of product, end user, and region. By product, the market is bifurcated into diagnostic devices, surgical devices, hearing aids, image-guided surgery systems, and others. By end user, the market is segmented into hospitals, ENT clinics, and others. Regionwise, the otorhinolaryngology devices market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2019 to 2026, which assist to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global otorhinolaryngology devicesmarket is provided.
An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.
KEY MARKET SEGMENTS
• By Product
o Diagnostic Devices
o Surgical Devices
o Hearing Aids
o Image-guided Surgery Systems
o Others
• By End User
o Hospitals
o ENT Clinics
o Others
• By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
Spain
Italy
UK
Rest of Europe
o Asia-Pacific
Australia
Japan
India
China
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Atos Medical AB
• Cochlear Ltd.
• Freudenberg SE (InHealth Technologies, Inc.)
• Hill-Rom Holdings, Inc.
• Johnson & Johnson (Acclarent, Inc.)
• Medtronic Plc.
• Olympus Corporation
• Sonova Group
• Starkey Hearing Technologies
• Stryker Corporation
The other players in the value chain (profiles not included in the report)
• Smith & Nephew plc
• Hoya Corporation
• William Demant Holdings A/S
• Stema Medizin
• Siemens Healthcare
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter's five force analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. High prevalence of chronic sinusitis
3.4.1.2. Rise in adoption of minimally invasive ENT procedures
3.4.1.3. Rapid growth in the elderly population
3.4.2. Restraints
3.4.2.1. Limited awareness and high costs
3.4.2.2. Government regulations and reimbursement issues
3.4.3. Opportunity
3.4.3.1. High growth prospects in emerging markets
CHAPTER 4: OTORHINOLARYNGOLOGY DEVICES MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Diagnostic Devices
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Surgical Devices
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Hearing Aids
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Image-guided Surgery Systems
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
4.6. Others
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
CHAPTER 5: GLOBAL OTORHINOLARYNGOLOGY DEVICES MARKET, BY END USER
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospitals
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. ENT Clinics
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Others
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
CHAPTER 6: OTORHINOLARYNGOLOGY DEVICES CAMERA MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.2.2. North America otorhinolaryngology devices market, by country
6.2.2.1. U.S. otorhinolaryngology devices market, by product
6.2.2.2. U.S. otorhinolaryngology devices market, by end user
6.2.2.3. Canada otorhinolaryngology devices market, by product
6.2.2.4. Canada otorhinolaryngology devices market, by end user
6.2.2.5. Mexico otorhinolaryngology devices market, by product
6.2.2.6. Mexico otorhinolaryngology devices market, by end user
6.2.3. North America otorhinolaryngology devices market, by product
6.2.4. North America otorhinolaryngology devices market, by end user
6.3. Europe
6.3.1. Key market trends and opportunities
6.3.2. Europe otorhinolaryngology devices market, by country
6.3.2.1. Germany otorhinolaryngology devices market, by product
6.3.2.2. Germany otorhinolaryngology devices market, by end user
6.3.2.3. France otorhinolaryngology devices market, by product
6.3.2.4. France otorhinolaryngology devices market, by end user
6.3.2.5. UK otorhinolaryngology devices market, by product
6.3.2.6. UK otorhinolaryngology devices market, by end user
6.3.2.7. Italy otorhinolaryngology devices market, by product
6.3.2.8. Italy otorhinolaryngology devices market, by end user
6.3.2.9. Spain otorhinolaryngology devices market, by product
6.3.2.10. Spain otorhinolaryngology devices market, by end user
6.3.2.11. Rest of Europe otorhinolaryngology devices market, by product
6.3.2.12. Rest of Europe otorhinolaryngology devices market, by end user
6.3.3. Europe otorhinolaryngology devices market, by product
6.3.4. Europe otorhinolaryngology devices market, by end user
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.4.2. Asia-Pacific otorhinolaryngology devices market, by country
6.4.2.1. Japan otorhinolaryngology devices market, by product
6.4.2.2. Japan otorhinolaryngology devices market, by end user
6.4.2.3. China otorhinolaryngology devices market, by product
6.4.2.4. China otorhinolaryngology devices market, by end user
6.4.2.5. Australia otorhinolaryngology devices market, by product
6.4.2.6. Australia otorhinolaryngology devices market, by end user
6.4.2.7. India otorhinolaryngology devices market, by product
6.4.2.8. India otorhinolaryngology devices market, by end user
6.4.2.9. South Korea otorhinolaryngology devices market, by product
6.4.2.10. South Korea otorhinolaryngology devices market, by end user
6.4.2.11. Rest of Asia-Pacific otorhinolaryngology devices market, by product
6.4.2.12. Rest of Asia-Pacific otorhinolaryngology devices market, by end user
6.4.3. Asia-Pacific otorhinolaryngology devices market, by product
6.4.4. Asia-Pacific otorhinolaryngology devices market, by end user
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. LAMEA otorhinolaryngology devices market, by country
6.5.2.1. Brazil otorhinolaryngology devices market, by product
6.5.2.2. Brazil otorhinolaryngology devices market, by end user
6.5.2.3. Saudi Arabia otorhinolaryngology devices market, by product
6.5.2.4. Saudi Arabia otorhinolaryngology devices market, by end user
6.5.2.5. South Africa otorhinolaryngology devices market, by product
6.5.2.6. South Africa otorhinolaryngology devices market, by end user
6.5.2.7. Rest of LAMEA otorhinolaryngology devices market, by product
6.5.2.8. Rest of LAMEA otorhinolaryngology devices market, by end user
6.5.3. LAMEA otorhinolaryngology devices market, by product
6.5.4. LAMEA otorhinolaryngology devices market, by end user
CHAPTER 7: COMPANY PROFILES
7.1. Atos Medical AB
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.2. Cochlear Ltd.
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. Freudenberg SE (InHealth Technologies, Inc.)
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. HILL-ROM HOLDINGS, INC.
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. Johnson & Johnson (Acclarent, Inc.)
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. Medtronic Plc.
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.7. Olympus Corporation
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments
7.8. Sonova Group
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. Starkey Hearing Technologies
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. Stryker Corporation
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...